USPTO serial 99712895
Serial No. 99712895
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- WOOD, DANIEL PAUL
- Law office
- TMO LAW OFFICE 132
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with Serial No. 99712895?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anthony E. Bennett
Anthony E. Bennett Hoffmann & Baron, LLP6900 Jericho TurnpikeSyosset, NY 11793United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 016 | Printed publications, namely, magazines in the field of immunotherapy; Printed posters; Printed pamphlets in the field of immunotherapy; Printed informational flyers and leaflets featuring information regarding immunotherapy; Printed newspapers; Printed matter in the nature of manual handbooks in the field of immunotherapy; Printed booklets in the field of immunotherapy; Printed magazines and journals featuring information about immunotherapy; Printed instructional and teaching material in the field of immunotherapy | ACTIVE | — |
| 035 | Advertising and marketing services; Providing consumer product information regarding medical products to patients and healthcare professionals; Advertising and marketing services featuring medical goods, medical testing and diagnostic products and services; Market research; Business strategy development services; Business planning; Business data analysis; Business management; Business organization consulting; Business administration; Retail store services, online retail store services, and wholesale store services featuring transdermal patches, skin patches and adhesive skin patches for medical use, transdermal and adhesive skin patches for treating, alleviating and preventing the development and progression of allergies and immunological disorders, transdermal and adhesive skin patches for the transdermal delivery of pharmaceuticals and medical preparations, patches and epicutaneous systems for the cutaneous and epicutaneous administration of medical and pharmaceutical substances for treating allergies and immunological disorders, adhesive patches and adhesive epicutaneous systems for cutaneous and epicutaneous administration of medical and pharmaceutical substances for treating allergies and immunological disorders, occlusive patches and occlusive epicutaneous systems for cutaneous and epicutaneous administration of powdered medical and pharmaceutical substances for treating allergies and immunological disorders, patches and epicutaneous systems containing a powdered preparation for medical and pharmaceutical use for treating allergies and immunological disorders, patches and epicutaneous systems for use in the treatment of allergies and immunological disorders, patches and epicutaneous systems featuring allergens and antigens for treating allergies and immunological disorders, allergy medication, pharmaceutical preparations for treating allergies, pharmaceutical preparations for treating food allergies; Retail store services, online retail store services and wholesale store services connected with the sale of medical instruments, apparatus and devices for the cutaneous, epicutaneous and patch-based administration and delivery of medical and pharmaceutical substances for the treatment, alleviation and prevention of allergies and immunological disorders, pads and skin patches for receiving, holding and containing medical and pharmaceutical substances for the treatment, alleviation and prevention of allergies and immunological disorders, pads and skin patches for medical training purposes, pads and skin patches for medical use, namely, for use in training medical professionals on the transdermal delivery of pharmaceuticals and medical preparations, medical instruments, apparatus and devices sold without medication for the later administration, by cutaneous and epicutaneous means, of medical and pharmaceutical substances, pad, skin patch and occlusion patch dispensers and applicators for medical use; advisory, information and consultancy services relating to all of the aforesaid | ACTIVE | — |
| 041 | Training services for consumers and medical professionals in the field of allergies and immunotherapy; Provision of classes, seminars, educational programs, educational conferences, congresses, and workshops in the field of allergies and immunotherapy; Organizing and providing exhibitions for online educational purposes featuring interactive presentations and exhibitions in the field of allergies and immunotherapy; Publication of periodicals, books, and catalogs in the fields of allergies and immunotherapy; information, advisory and consultancy services relating to all of the aforesaid | ACTIVE | — |
| 042 | Medical and scientific research in the fields of allergies and immunotherapy; Development services of scientific methods for cutaneous and epicutaneous immunotherapy; Medical and scientific research relating to the treatment, alleviation and prevention of autoimmune, infectious and inflammatory diseases; Medical and scientific research in the fields of allergy treatment and care; Allergenic drug discovery services; Medical and scientific research services, namely, developing methods for treating allergies via contact between allergens and the skin; Medical and scientific research services, namely, developing methods for the treatment and prevention of allergies, autoimmune, infectious and inflammatory diseases by applying patches to patients' skin; information, advisory and consultancy services relating to all of the aforesaid | ACTIVE | — |
| 044 | Medical services relating to the treatment, alleviation and prevention of allergies; medical treatment, alleviation and prevention of allergies, inflammatory, autoimmune and infectious diseases through the administration of medical and pharmaceutical substances, allergens and antigens using patches affixed to patients' skin; medical consultancy in the field of desensitization to allergies; providing medical information regarding medical conditions, allergies, intolerances, treatments and products to patients and healthcare professionals; provision of medical advice to patients and healthcare professionals regarding medical conditions, allergies, intolerances and treatment; providing medical information regarding medical products to patients and healthcare professionals; information, advisory and consultancy services relating to all of the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DBV TECHNOLOGIES
- Other trademarks owned by DBV TECHNOLOGIES
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 6, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 30, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 10, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 31, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 31, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 31, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 8, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 26, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 18, 2026 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 18, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 19, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 19, 2026 | NWAP | NEW APPLICATION ENTERED | — |